ZhuRX,SetoWK,LaiCL,YuenMF, 2016.Epidemiology of hepatocellular carcinoma in the asia-pacific region,Gut Liver 10 332 -9
ButtAS,HamidS,WadalawalaAA,GhufranM,JavedAA,FarooqO, 2013.Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral- hepatocellular carcinoma,BMC Res Notes 6 137 -
FilmusJ,CapurroM, 2013.Glypican-3: A marker and a therapeutic target in hepatocellular carcinoma,FEBS J 280 2471 -6
KewMC, 2010.Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma,Pathol Biol 58 273 -7
ChenJH,WangYY,LvWB,GanY,ChangW,TianNN, 2016.Effects of interactions between environmental factors and KIF1B genetic variants on the risk of hepatocellular carcinoma in a Chinese cohort,World J Gastroenterol 22 4183 -90
TorreLA,BrayF,SiegelRL,FerlayJ,Lortet-TieulentJ,JemalA, 2015.,2012. CA Cancer J Clin 65 87 -108
GohGB,ChangPE,TanCK, 2015.Changing epidemiology of hepatocellular carcinoma in Asia,Best Pract Res Clin Gastroenterol 29 919 -28
AhmadZ,ArshadH,FatimaS,IdreesR,Ud-DinN,AhmedR, 2013.Gastrointestinal, liver and biliary tract pathology: A histopathological and epidemiological perspective from Pakistan with a review of the literature,Asian Pac J Cancer Prev 14 6997 -7005
El-SeragHB, 2012.Epidemiology of viral hepatitis and hepatocellular carcinoma,Gastroenterology 142 1264 -73
YangJD,RobertsLR, 2010.Hepatocellular carcinoma: A global view,Nat Rev Gastroenterol Hepatol 7 448 -58
ZaakookM,AyoubM,SinnaEA,El-Sheikh S, 2013.Role of glypican-3 immunocytochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver utilizing fine needle aspiration cytology,J Egypt Natl Canc Inst 25 173 -80
YanB,WeiJ,QianY,ZhaoX,ZhangW,XuA, 2011.Expression and clinicopathologic significance of glypican 3 in hepatocellular carcinoma,Ann Diagn Pathol 15 162 -9
FengM,HoM, 2014.Glypican-3 antibodies: A new therapeutic target for liver cancer,FEBS Lett 588 377 -82
WangFH,YipYC,ZhangM,VongHT,ChanKI,WaiKC, 2010.Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy,J Clin Pathol 63 599 -603
AnatelliF,ChuangST,YangXJ,WangHL, 2008.Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy,Am J Clin Pathol 130 219 -23
WangHL,AnatelliF,ZhaiQJ,AdleyB,ChuangST,YangXJ, 2008.Glypican-3 as a Useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions,Arch Pathol Lab Med 132 1723 -8
HoM,Kim H, 2011.Glypican-3: A new target for cancer immunotherapy,Eur J Cancer 47 333 -8
KringsG,RamachandranR,JainD,WuTT,YehMM,TorbensonM, 2013.Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma,Mod Pathol 26 782 -91